Virtual, Interactive Conference!

Saturday, November 7, 2020 - 7:00 AM - 5:30 PM EST

At the 15th Annual New York Lung Cancers Symposium^®, you will experience a comprehensive overview of lung cancer diagnoses and multidisciplinary treatment. The agenda is designed to help you increase your knowledge and competence of lung cancer therapy, starting with the roles that surgery, radiology, pulmonology, and pathology play in ensuring the most accurate diagnosis of lung cancers. You will hear experts from the New York area discuss optimal approaches for early-stage and locally advanced disease, as well as present the latest data on immunotherapy and targeted agents in metastatic lung cancers. Finally, you will get a preview of upcoming advances in local and systemic therapies for thoracic malignancies.

As in previous years, interactive case challenges will provide you with an opportunity to discuss the application of clinical data to real-world patient cases. For nurse practitioners and physician assistants, a special session will provide opportunities for learning and networking. We look forward to offering you this exciting meeting, centered on lung cancers, that will foster collaboration between you and other members of the multidisciplinary oncology team. This is a program you won’t want to miss!

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, and pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, investigators, and other healthcare professionals interested in the treatment of lung cancer may also participate.

This activity is supported by educational grants from AstraZeneca; Blueprint Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo, Inc.; Integrated Oncology - a LabCorp Specialty Testing Group; Jazz Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation, and Pfizer Inc.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, is approved by the California Board of Registered Nursing, Provider #16669, for 8.25 Contact Hours.